Ignite Creation Date:
2024-05-06 @ 8:18 PM
Last Modification Date:
2024-10-26 @ 3:24 PM
Study NCT ID:
NCT06330064
Status:
RECRUITING
Last Update Posted:
2024-04-16
First Post:
2024-03-19
Brief Title:
A Study To Evaluate The Efficacy And Safety Of Ifinatamab Deruxtecan I-DXd In Subjects With Recurrent Or Metastatic Solid Tumors IDeate-PanTumor02
Sponsor:
Daiichi Sankyo
Organization:
Daiichi Sankyo
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Recurrent or Metastatic Solid Tumors |
Keywords:
| Name | View |
|---|---|
| DS7300a | View |
| Recurrent or metastatic solid tumors | View |
| Endometrial cancer | View |
| Head and neck squamous cell carcinoma | View |
| Pancreatic ductal adenoarcinoma | View |
| Colorectal cancer | View |
| Hepatocellular carcinoma | View |
| Adenocarcinoma of esophagus gastroesophageal junction and stomach | View |
| Non-squamous non-small cell lung cancer | View |
| Urothelial carcinoma | View |
| Ifinatamab deruxtecan I-DXD | View |